{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:54:31Z","timestamp":1792079671133,"version":"4.4.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jurology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.juro.2017.10.018","type":"journal-article","created":{"date-parts":[[2017,10,14]],"date-time":"2017-10-14T07:05:09Z","timestamp":1507964709000},"page":"998-1003","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Intratrigonal OnabotulinumtoxinA Improves Bladder Symptoms and Quality of Life in Patients with Bladder Pain Syndrome\/Interstitial Cystitis: A Pilot, Single Center, Randomized, Double-Blind, Placebo Controlled Trial"],"prefix":"10.1097","volume":"199","author":[{"given":"Rui Almeida","family":"Pinto","sequence":"first","affiliation":[{"name":"Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade (i3S), Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Costa","sequence":"additional","affiliation":[{"name":"Department of Urology, Hospital de S\u00e3o Jo\u00e3o, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afonso","family":"Morgado","sequence":"additional","affiliation":[{"name":"Department of Urology, Hospital de S\u00e3o Jo\u00e3o, Porto, Portugal"},{"name":"Faculty of Medicine of Porto, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Pereira","sequence":"additional","affiliation":[{"name":"Department of Urology, Hospital de S\u00e3o Jo\u00e3o, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Charrua","sequence":"additional","affiliation":[{"name":"Faculty of Medicine of Porto, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Silva","sequence":"additional","affiliation":[{"name":"Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade (i3S), Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Cruz","sequence":"additional","affiliation":[{"name":"Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade (i3S), Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2017.10.018_bib1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eururo.2007.09.019","article-title":"Diagnostic criteria, classification, and nomenclature for painful bladder syndrome\/interstitial cystitis: an ESSIC proposal","volume":"53","author":"Van de Merwe","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2017.10.018_bib2","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.eururo.2013.04.035","article-title":"The 2013 EAU guidelines on chronic pelvic pain: is management of chronic pelvic pain a habit, a philosophy, or a science? 10 years of development","volume":"64","author":"Engeler","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2017.10.018_bib3","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/j.juro.2009.12.106","article-title":"Effect of amitriptyline on symptoms in treatment na\u00efve patients with interstitial cystitis\/painful bladder syndrome","volume":"183","author":"Foster","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2017.10.018_bib4","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/01.ju.0000083020.06212.3d","article-title":"A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis","volume":"170","author":"Sant","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2017.10.018_bib5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.eururo.2011.07.069","article-title":"Contemporary management of the painful bladder: a systematic review","volume":"61","author":"Giannantoni","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2017.10.018_bib6","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1097\/01.ju.0000154631.92150.ef","article-title":"Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, double-blind, placebo controlled trial","volume":"173","author":"Payne","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2017.10.018_bib7","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.urology.2009.09.078","article-title":"Intravesical instillation of hyaluronic acid prolonged the effect of bladder hydrodistention in patients with severe interstitial cystitis","volume":"75","author":"Shao","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.juro.2017.10.018_bib8","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.urology.2010.03.016","article-title":"A multicenter, randomized, double-blind, parallel group pilot evaluation of the efficacy and safety of intravesical sodium chondroitin sulfate versus vehicle control in patients with interstitial cystitis\/painful bladder syndrome","volume":"76","author":"Nickel","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.juro.2017.10.018_bib9","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/nau.23024","article-title":"Hydrodistention of the bladder for the treatment of bladder pain syndrome\/interstitial cystitis (BPS\/IC)","volume":"36","author":"Hoke","year":"2017","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.juro.2017.10.018_bib10","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/j.juro.2012.01.123","article-title":"Randomized multicenter clinical trial of myofascial physical therapy in women with interstitial cystitis\/painful bladder syndrome and pelvic floor tenderness. Interstitial Cystitis Collaborative Research Network","volume":"187","author":"FitzGerald","year":"2012","journal-title":"J Urol"},{"issue":"suppl.","key":"10.1016\/j.juro.2017.10.018_bib11","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1016\/j.juro.2012.11.018","article-title":"Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. Urological Pelvic Pain Collaborative Research Network","volume":"189","author":"Fitzgerald","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2017.10.018_bib12","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.urology.2004.06.073","article-title":"Botulinum toxin A has antinociceptive effects in treating interstitial cystitis","volume":"64","author":"Smith","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.juro.2017.10.018_bib13","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.eururo.2010.02.031","article-title":"Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome\/interstitial cystitis","volume":"58","author":"Pinto","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2017.10.018_bib14","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0306-4522(01)00496-1","article-title":"Vanilloid receptor 1 expression in the rat urinary tract","volume":"109","author":"Avelino","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.juro.2017.10.018_bib15","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.juro.2006.10.047","article-title":"Botulinum toxin type A injections into the trigone to treat idiopathic overactive bladder do not induce vesicoureteral reflux","volume":"177","author":"Karsenty","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2017.10.018_bib16","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.juro.2012.09.027","article-title":"Persistent therapeutic effect of repeated injections of onabotulinum toxin A in refractory bladder pain syndrome\/interstitial cystitis","volume":"189","author":"Pinto","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2017.10.018_bib17","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.urology.2008.05.033","article-title":"Validation of treatment benefit scale for assessing subjective outcomes in treatment of overactive bladder","volume":"72","author":"Colman","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.juro.2017.10.018_bib18","first-page":"1","article-title":"Comparison of intravesical botulinum toxin type A injections plus hydrodistension with hydrodistension alone for the treatment of refractory interstitial cystitis\/painful bladder syndrome","volume":"1","author":"Kuo","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2017.10.018_bib19","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.eururo.2012.10.005","article-title":"A randomized double blind placebo-controlled phase 2 dose-ranging study of onabotulinumtoxinA in men with benign prostatic hyperplasia","volume":"63","author":"Marberger","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2017.10.018_bib20","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.eururo.2012.03.031","article-title":"Botulinum neurotoxin serotype A suppresses neurotransmitter release from afferent as well as efferent nerves in the urinary bladder","volume":"62","author":"Ikeda","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2017.10.018_bib21","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.neuint.2004.06.001","article-title":"Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury","volume":"45","author":"Khera","year":"2004","journal-title":"Neurochem Int"},{"key":"10.1016\/j.juro.2017.10.018_bib22","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1113\/jphysiol.2005.088435","article-title":"P2X2 knockout mice and P2X2\/P2X3 double knockout mice reveal a role for the P2X2 receptor subunit in mediating multiple sensory effects of ATP","volume":"567","author":"Cockayne","year":"2005","journal-title":"J Physiol"},{"key":"10.1016\/j.juro.2017.10.018_bib23","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.nbd.2012.07.010","article-title":"Reduction of TRPV1 expression in the trigeminal system by botulinum neurotoxin type-A","volume":"48","author":"Shimizu","year":"2012","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.juro.2017.10.018_bib24","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.eururo.2009.12.022","article-title":"Distribution of the high-affinity binding site and intracellular target of botulinum toxin type A in the human bladder","volume":"57","author":"Coelho","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2017.10.018_bib25","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/nau.23224","article-title":"Beta-3 adrenergic receptor is expressed in acetylcholine-containing nerve fibers of the human urinary bladder: an immunohistochemical study","volume":"36","author":"Coelho","year":"2017","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.juro.2017.10.018_bib26","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/nau.22900","article-title":"Expression of cleaved SNAP-25 after bladder wall injection of onabotulinumtoxin A or abobotulinumtoxin A: a comparative study in the mice","volume":"36","author":"Oliveira","year":"2017","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.juro.2017.10.018_bib27","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/nau.23052","article-title":"Less is more\u2014a pilot study evaluating one to three intradetrusor sites for injection of onabotulinum toxin A for neurogenic and idiopathic detrusor overactivity","volume":"36","author":"Avallone","year":"2017","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.juro.2017.10.018_bib28","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.urology.2014.01.018","article-title":"Ulcerative and nonulcerative forms of bladder pain syndrome\/interstitial cystitis do not differ in symptom intensity or response to onabotulinum toxin A","volume":"83","author":"Pinto","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.juro.2017.10.018_bib29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.eururo.2013.04.001","article-title":"OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial","volume":"64","author":"Chapple","year":"2013","journal-title":"Eur Urol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534717777233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534717777233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2017.10.018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T05:02:42Z","timestamp":1651208562000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2017.10.018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["10.1016\/j.juro.2017.10.018"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2017.10.018","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intratrigonal OnabotulinumtoxinA Improves Bladder Symptoms and Quality of Life in Patients with Bladder Pain Syndrome\/Interstitial Cystitis: A Pilot, Single Center, Randomized, Double-Blind, Placebo Controlled Trial","name":"articletitle","label":"Article Title"},{"value":"The Journal of Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.juro.2017.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by AMERICAN UROLOGICAL ASSOCIATION EDUCATION AND RESEARCH, INC.","name":"copyright","label":"Copyright"}]}}